A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK’s NHS long term plan
PLOS Global Public Health · 25.04.2023 · 3 (4) · e0001795
DOI: 10.1371/journal.pgph.0001795 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 25.04.2023. Verfasst von Christopher Page und 7 weiteren Autor:innen. Beteiligte Einrichtung: Personalised Medicine Centre, School of Biomedical Science, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Derry, Northern Ireland, U…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department for the Economy, Northern Ireland, Health and Social Care Northern Ireland.
Abstract (Originalsprache)
We sought to determine the most efficacious and cost-effective strategy to follow when developing a national screening programme by comparing and contrasting the national screening programmes of Norway, the Netherlands and the UK. Comparing the detection rates and screening profiles between the Netherlands, Norway, the UK and constituent nations (England, Northern Ireland, Scotland and Wales) it is clear that maximising the number of relatives screened per index case leads to identification of the greatest proportion of an FH population. The UK has stated targets to detect 25% of the population of England with FH across the 5 years to 2024 with the NHS Long Term Plan. However, this is grossly unrealistic and, based on pre-pandemic rates, will only be reached in the year 2096. We also modelled the efficacy and cost-effectiveness of two screening strategies: 1) Universal screening of 1-2-year-olds, 2) electronic healthcare record screening, in both cases coupled to reverse cascade screening. We found that index case detection from electronic healthcare records was 56% more efficacious than universal screening and, depending on the cascade screening rate of success, 36%-43% more cost-effective per FH case detected. The UK is currently trialling universal screening of 1–2-year-olds to contribute to national FH detection targets. Our modelling suggests that this is not the most efficacious or cost-effective strategy to follow. For countries looking to develop national FH programmes, screening of electronic healthcare records, coupled to successful cascade screening to blood relatives is likely to be a preferable strategy to follow.
Autor:innen und Institutionen
- Personalised Medicine Centre, School of Biomedical Science, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Derry, Northern Ireland, United Kingdom.
- School of Computing, Ulster University, Belfast, Northern Ireland, United Kingdom.
- Personalised Medicine Centre, School of Medicine, Ulster University, Derry, Northern Ireland, United Kingdom.
- Western Health and Social Care Trust, Altnagelvin Area Hospital, Derry, Northern Ireland, United Kingdom.
- Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom.
ORCID-Profile: Steven Watterson
Förderung
- Department for the Economy, Northern Ireland
- Health and Social Care Northern Ireland
Zitieren
APA
Page, C., Zheng, H., Wang, H., Rai, T. S., O'Kane, M., Hart, P., McKee, S., & Watterson, S. (2023). A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK’s NHS long term plan. PLOS Global Public Health, 3(4), e0001795. https://doi.org/10.1371/journal.pgph.0001795
Vancouver
Page C, Zheng H, Wang H, Rai TS, O'Kane M, Hart P, et al. A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK’s NHS long term plan. PLOS Global Public Health. 2023;3(4):e0001795. doi:10.1371/journal.pgph.0001795
BibTeX
@article{Page2023,
author = {Page, Christopher and Zheng, Huiru and Wang, Haiying and Rai, Taranjit Singh and O'Kane, Maurice and Hart, Pádraig and McKee, Shane and Watterson, Steven},
title = {A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK’s NHS long term plan},
journal = {PLOS Global Public Health},
year = {2023},
volume = {3},
number = {4},
pages = {e0001795},
doi = {10.1371/journal.pgph.0001795}
}
EUVIMED